Akari Therapeutics PlcAkari Therapeutics PlcAkari Therapeutics Plc

Akari Therapeutics Plc

No trades
See on Supercharts

AKTX fundamentals

An in-depth look to Akari Therapeutics Plc operating, investing, and financing activities

AKTX free cash flow for Q1 24 is -4.04 M USD. For 2023, AKTX free cash flow was -16.43 M USD and operating cash flow was -16.43 M USD.

Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q1 '23
Q1 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q1 '23
Q1 '24
TTM
Free cash flowYoY growth